Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

721
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
721

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-129-3p Targeting of MCU Protects Against Glucose Fluctuation-Mediated Neuronal Damage via a Mitochondrial-Dependent Intrinsic Apoptotic Pathway.

Diabetes, metabolic syndrome and obesity : targets and therapy·2021
Same author

Malignancy Risk Stratification Prediction of Amorphous Calcifications Based on Clinical and Mammographic Features.

Cancer management and research·2021
Same author

Comparison of clinical and histopathological characteristics of short-term progressive and non-progressive blood blister-like aneurysms.

Acta neurochirurgica·2021
Same author

Duration and choices of prophylactic anticonvulsants in subarachnoid hemorrhage: a systematic review and meta-analysis.

Neurosurgical review·2021
Same author

Changes in Characteristics, Treatment and Outcome in Patients with Hemorrhagic Stroke During COVID-19.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2020
Same author

Mass Detection and Segmentation in Digital Breast Tomosynthesis Using 3D-Mask Region-Based Convolutional Neural Network: A Comparative Analysis.

Frontiers in molecular biosciences·2020

Related Experiment Video

Updated: Mar 9, 2026

Controlled Cortical Impact Model for Traumatic Brain Injury
05:30

Controlled Cortical Impact Model for Traumatic Brain Injury

Published on: August 5, 2014

29.8K

Progesterone for acute traumatic brain injury.

Junpeng Ma1, Siqing Huang1, Shu Qin1

  • 1Department of Neurosurgery, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China, 610041.

The Cochrane Database of Systematic Reviews
|December 23, 2016
PubMed
Summary

Progesterone does not appear to improve outcomes for traumatic brain injury (TBI) patients. This updated review found no evidence of reduced mortality or disability, though study inconsistencies limit confidence.

More Related Videos

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
06:50

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation

Published on: June 10, 2020

2.4K
Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury
05:01

Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury

Published on: August 16, 2019

11.3K

Related Experiment Videos

Last Updated: Mar 9, 2026

Controlled Cortical Impact Model for Traumatic Brain Injury
05:30

Controlled Cortical Impact Model for Traumatic Brain Injury

Published on: August 5, 2014

29.8K
A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
06:50

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation

Published on: June 10, 2020

2.4K
Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury
05:01

Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury

Published on: August 16, 2019

11.3K

Area of Science:

  • Neuroscience
  • Clinical Medicine
  • Pharmacology

Background:

  • Traumatic brain injury (TBI) is a significant cause of death and disability globally.
  • Progesterone, a neurosteroid, has potential therapeutic properties for TBI due to its central nervous system actions.
  • Existing evidence on progesterone's efficacy for TBI requires updated evaluation.

Purpose of the Study:

  • To evaluate the impact of progesterone on neurological outcomes, mortality, and disability in acute TBI patients.
  • To assess the safety profile of progesterone treatment in individuals with acute TBI.

Main Methods:

  • An updated systematic review and meta-analysis of randomized controlled trials (RCTs) comparing progesterone to placebo in acute TBI.
  • Searches conducted across major databases including Cochrane, MEDLINE, Embase, and Web of Science up to September 2016.
  • Five RCTs involving 2392 participants were included, with risk of bias assessed for each study.

Main Results:

  • Low-quality evidence indicates no significant difference in overall mortality (RR 0.91) or disability (RR 0.98) between progesterone and placebo groups.
  • Moderate-quality evidence for disability outcomes was limited by inconsistency across studies.
  • No significant differences were observed in intracranial pressure, blood pressure, or body temperature; however, intravenous progesterone was associated with increased phlebitis risk in one study.

Conclusions:

  • This updated review found no evidence that progesterone reduces mortality or disability in TBI patients.
  • Inconsistencies across studies limit the confidence in these findings.
  • Progesterone therapy did not show increased adverse events compared to placebo, except for phlebitis in one study; further research with refined TBI classification and optimized dosing is recommended.